Efficacy of telavancin in the treatment of experimental endocarditis due to glycopeptide-intermediate Staphylococcus aureus (Q35879100)

From Wikidata
Jump to navigation Jump to search
scientific article published on 7 May 2007
edit
Language Label Description Also known as
English
Efficacy of telavancin in the treatment of experimental endocarditis due to glycopeptide-intermediate Staphylococcus aureus
scientific article published on 7 May 2007

    Statements

    Efficacy of telavancin in the treatment of experimental endocarditis due to glycopeptide-intermediate Staphylococcus aureus (English)
    Cristina García-de-la-Mària
    Elisa de-Lazzari
    Asunción Moreno
    Carlos A Mestres
    José M Gatell
    María-Teresa Jiménez-de-Anta
    Francesc Marco
    Hospital Clínic Experimental Endocarditis Study Group

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit